[{"address1": "4000 Shoreline Court", "address2": "Suite 300", "city": "South San Francisco", "state": "CA", "zip": "94080", "country": "United States", "phone": "650 822 5600", "website": "https://www.kezarlifesciences.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases in the United States. The company's lead product candidate is zetomipzomib (KZR-616), a selective immunoproteasome inhibitor for various indications, including lupus nephritis, dermatomyositis, and polymyositis; and Phase 1b/2 clinical trials in systemic lupus erythematosus. It is also developing KZR-261, a novel first-in-class protein secretion inhibitor for the treatment of tumors resistant to traditional chemotherapeutics. Kezar Life Sciences, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.", "fullTimeEmployees": 55, "companyOfficers": [{"maxAge": 1, "name": "Dr. Christopher J. Kirk Ph.D.", "age": 52, "title": "Co-Founder, CEO & Director", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 927300, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John Franklin Fowler", "age": 52, "title": "Co-Founder & Director", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 57037, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Marc L. Belsky CPA", "age": 69, "title": "CFO & Secretary", "yearBorn": 1955, "fiscalYear": 2024, "totalPay": 653208, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark  Schiller", "age": 44, "title": "Chief Legal Officer", "yearBorn": 1980, "fiscalYear": 2024, "totalPay": 637985, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jack  Taunton Ph.D.", "title": "Co-Founder", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Pattie  Chiang", "age": 62, "title": "Principal Accounting Officer, Senior VP & Corporate Controller", "yearBorn": 1962, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Gitanjali  Jain", "title": "Senior Vice President of Investor Relations & External Affairs", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Joe  Tedrick", "title": "Vice President of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Neel K. Anand Ph.D.", "title": "Senior Vice President of Research & Drug Discovery", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Zung  To", "title": "Senior Vice President of Clinical Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 7, "compensationRisk": 10, "shareHolderRightsRisk": 10, "overallRisk": 10, "governanceEpochDate": 1748736000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 4.79, "open": 4.73, "dayLow": 4.51, "dayHigh": 4.75, "regularMarketPreviousClose": 4.79, "regularMarketOpen": 4.73, "regularMarketDayLow": 4.51, "regularMarketDayHigh": 4.75, "payoutRatio": 0.0, "beta": 0.573, "forwardPE": -0.43075454, "volume": 12967, "regularMarketVolume": 12967, "averageVolume": 33663, "averageVolume10days": 27860, "averageDailyVolume10Day": 27860, "bid": 3.39, "ask": 5.96, "bidSize": 2, "askSize": 2, "marketCap": 32949160, "fiftyTwoWeekLow": 3.62, "fiftyTwoWeekHigh": 9.2, "fiftyDayAverage": 4.3212, "twoHundredDayAverage": 5.89055, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -66790436, "profitMargins": 0.0, "floatShares": 4902630, "sharesOutstanding": 7305800, "sharesShort": 52900, "sharesShortPriorMonth": 53859, "sharesShortPreviousMonthDate": 1747267200, "dateShortInterest": 1749772800, "sharesPercentSharesOut": 0.0072000003, "heldPercentInsiders": 0.1157, "heldPercentInstitutions": 0.59284, "shortRatio": 2.23, "shortPercentOfFloat": 0.0074, "impliedSharesOutstanding": 7759380, "bookValue": 14.108, "priceToBook": 0.3196768, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -78634000, "trailingEps": -10.78, "forwardEps": -10.47, "lastSplitFactor": "1:10", "lastSplitDate": 1730246400, "enterpriseToEbitda": 0.814, "52WeekChange": -0.29531252, "SandP52WeekChange": 0.1116153, "quoteType": "EQUITY", "currentPrice": 4.51, "targetHighPrice": 18.0, "targetLowPrice": 7.0, "targetMeanPrice": 12.5, "targetMedianPrice": 12.5, "recommendationKey": "none", "numberOfAnalystOpinions": 2, "totalCash": 114361000, "totalCashPerShare": 15.653, "ebitda": -82022000, "totalDebt": 14110000, "quickRatio": 6.871, "currentRatio": 7.093, "debtToEquity": 13.69, "returnOnAssets": -0.32004002, "returnOnEquity": -0.57779, "grossProfits": -65742000, "freeCashflow": -42950624, "operatingCashflow": -68540000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "KZR", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "longName": "Kezar Life Sciences, Inc.", "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -10.78, "epsForward": -10.47, "epsCurrentYear": -7.06, "priceEpsCurrentYear": -0.6388102, "fiftyDayAverageChange": 0.18880033, "fiftyDayAverageChangePercent": 0.043691646, "twoHundredDayAverageChange": -1.3805499, "twoHundredDayAverageChangePercent": -0.2343669, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1752264254, "regularMarketTime": 1752264000, "exchange": "NCM", "messageBoardId": "finmb_304157325", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -5.845506, "regularMarketPrice": 4.51, "marketState": "CLOSED", "shortName": "Kezar Life Sciences, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1529587800000, "postMarketChangePercent": -0.22123346, "postMarketPrice": 4.51, "postMarketChange": -0.009999752, "regularMarketChange": -0.27999973, "regularMarketDayRange": "4.51 - 4.75", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 33663, "fiftyTwoWeekLowChange": 0.89000034, "fiftyTwoWeekLowChangePercent": 0.24585645, "fiftyTwoWeekRange": "3.62 - 9.2", "fiftyTwoWeekHighChange": -4.6899996, "fiftyTwoWeekHighChangePercent": -0.50978255, "fiftyTwoWeekChangePercent": -29.531252, "earningsTimestamp": 1747166460, "earningsTimestampStart": 1755201600, "earningsTimestampEnd": 1755201600, "displayName": "Kezar Life Sciences", "trailingPegRatio": null, "__fetch_time": "2025-07-12"}]